Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
5.67 x 1 5.72 x 4
Post-market by (Cboe BZX)
5.72 unch (unch) 02/13/25 [NYSE]
5.67 x 1 5.72 x 4
Post-market 5.73 +0.01 (+0.17%) 16:01 ET
News & Headlines for Thu, Feb 13th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 18.14 (+1.97%)
NVRO : 5.72 (unch)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX

For Immediate ReleaseChicago, IL – December 11, 2024 – Stocks in this week’s article are Stryve Foods SNAX, Nevro NVRO, Canoo GOEV, MSA Safety Inc. MSA and VTEX VTEX.Bet on 5 Top-Ranked Stocks with...

NVRO : 5.72 (unch)
SNAX : 0.8080 (+18.81%)
GOEV : 0.3700 (-9.60%)
VTEX : 6.32 (+1.44%)
MSA : 163.28 (+0.24%)
Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock...

NVRO : 5.72 (unch)
SNAX : 0.8080 (+18.81%)
GOEV : 0.3700 (-9.60%)
VTEX : 6.32 (+1.44%)
MSA : 163.28 (+0.24%)
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro: Q1 Earnings Snapshot

Nevro: Q1 Earnings Snapshot

NVRO : 5.72 (unch)
Why Nevro Stock Lagged the Market on Thursday

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

NVRO : 5.72 (unch)
Nevro: Q4 Earnings Snapshot

Nevro: Q4 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro: Q3 Earnings Snapshot

Nevro: Q3 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro to Report Third Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Announces Participation in Upcoming Investor Conferences

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 5.72 (unch)
New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 5.72 (unch)
Why Shares of Nevro Are Down Wednesday

The medical device maker saw increased revenue, but earnings lagged estimates.

NVRO : 5.72 (unch)
Nevro: Q2 Earnings Snapshot

Nevro: Q2 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro to Report Second Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Names New Chief Commercial Officer

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro to Present at Jefferies Healthcare Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company Manual

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro: Q1 Earnings Snapshot

Nevro: Q1 Earnings Snapshot

NVRO : 5.72 (unch)
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Announces Enrollment of First Patient in PDN Sensory Study

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro Announces Participation in Upcoming Investor Conferences

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Why Nevro Stock Is Tanking Today

The moody market is punishing this medical device stock yet again today.

NVRO : 5.72 (unch)
Nevro Names Kevin Thornal as New Chief Executive Officer and President

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)
Nevro to Report First Quarter 2023 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 5.72 (unch)

Barchart Exclusives

1 Top-Rated Dividend Stock to Buy for February 2025
Investors seeking stable cash flow could snag this 'Strong Buy'-rated dividend stock this month for solid returns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion